DNA Script
Transforming how molecular biology translates to human health, personalized medicine and synthetic biology
Transforming how molecular biology translates to human health, personalized medicine and synthetic biology
DNA Script is a French biotechnology startup founded in 2014 with a focus on transforming molecular biology for human health, personalized medicine, and synthetic biology. The company's mission is reflected in its slogan, "Transforming how molecular biology translates to human health, personalized medicine and synthetic biology." DNA Script's core research and development efforts have led to groundbreaking innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. This has culminated in the development of SYNTAX™️, the world’s first benchtop DNA printer powered by enzymatic technology. With a recent Seed Round investment on 27 August 2022 led by Hedonova, DNA Script is well-positioned to drive advancements in enzymatic DNA synthesis technology and contribute significantly to genomics research and personalized medicine.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 1 |
|
27 Aug 2022 |
| Series C | $200.00M | 10 |
|
04 Jan 2022 |
| Grant | $2.20M | 1 |
|
09 Nov 2021 |
| Series C | $165.00M | 10 |
|
26 Oct 2021 |
| Series B | $50.00M | 7 |
|
29 Jul 2020 |
No recent news or press coverage available for DNA Script.
We care about your data, and we'd love to use cookies make your experience better.
